Medicine and Dentistry
Endoscopic Ultrasound
100%
Neoplasm
66%
Echography
57%
Diagnosis
34%
Pancreas Cancer
29%
Pancreas Disease
29%
Pancreatic Duct
28%
Autoimmune Pancreatitis
27%
Capsule Endoscopy
26%
Double-Balloon Enteroscopy
21%
Elastography
21%
Disease
20%
Chronic Pancreatitis
20%
Intraductal Papillary Mucinous Tumor
19%
Adenoma
17%
Malignant Neoplasm
16%
Surgery
16%
Stomach Cancer
15%
Fine-Needle Aspiration
15%
Endoscopic Ultrasound Guided Fine Needle Biopsy
14%
Bile Duct
14%
Crohn's Disease
13%
Differential Diagnosis
13%
Colon
13%
Diagnostic Accuracy
13%
Stenosis
12%
Polyp
12%
Endoscopic Retrograde Cholangiopancreatography
12%
Cancer
11%
Endoscopic Submucosal Dissection
11%
Endoscopy
11%
Endoscopic Papillotomy
11%
Ultrasound Elastography
11%
Narrow Band Imaging
11%
Mucin
10%
Bleeding
10%
Hepatocellular Carcinoma
10%
Adenocarcinoma
10%
Shear Wave Elastography
10%
Neuroendocrine Tumor
10%
Cholangiocarcinoma
10%
Esophagus
10%
Biopsy
10%
Cholestasis
10%
Angiography
9%
Ribavirin
9%
Interferon
9%
Combination Therapy
9%
Carcinoma
9%
Adverse Event
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
31%
Pancreas Cancer
18%
Combination Therapy
16%
Hepatitis B Virus
15%
Neoplasm
15%
Disease
15%
Hepatitis C Virus
13%
Bevacizumab
13%
Atezolizumab
13%
Chronic Hepatitis C
12%
Crohn's Disease
11%
Interferon
11%
Ribavirin
11%
Malignant Neoplasm
10%
Acute Hepatitis B
9%
Gemcitabine
9%
Autoimmune Pancreatitis
8%
Sorafenib
8%
Stomach Cancer
8%
Lamivudine
8%
Bleeding
8%
Retrospective Study
8%
Chemotherapy
8%
Asunaprevir
8%
Daclatasvir
8%
Prevalence
7%
Chronic Hepatitis B
7%
Adverse Event
7%
Gastrointestinal Hemorrhage
6%
Peginterferon
6%
Hepatitis C Virus Subtype 1b
6%
Pancreas Adenocarcinoma
6%
Prospective Study
6%
Intraductal Papillary Mucinous Tumor
6%
Polyp
6%
Overall Survival
6%
Antiviral Therapy
5%
Remission
5%
Epileptic Absence
5%
Bilirubin
5%
Peginterferon Alpha2b
5%
Fibrosis
5%
Keyphrases
Endoscopic Ultrasonography
15%
Pancreas
11%
Intraductal Papillary mucinous Neoplasm
11%
Advanced Hepatocellular Carcinoma
11%
Atezolizumab Plus Bevacizumab
11%
Combination Therapy
10%
Sustained Virological Response
9%
Endoscopic Ultrasound
9%
Hepatitis C Virus
9%
IgG4-related Sclerosing Cholangitis
8%
Japan
8%
Intraductal Ultrasonography
8%
Autoimmune Pancreatitis
7%
Hepatitis C Virus Genotypes
7%
Pancreatic Cancer
7%
Ribavirin
7%
Interferon Sensitivity-determining Region
6%
Differential Diagnosis
6%
Intraductal Ultrasound
6%
Elastography
6%
Mucin-producing Tumor
6%
Main Pancreatic Duct
6%
Pancreatic Diseases
5%
Clinical Outcomes
5%
Chronic Pancreatitis
5%
Esophagus
5%
Pegylated Interferon alfa-2a
5%
Lymph Node Metastasis
5%